News
Boletín mensual del IDIS – Noviembre 2023
Ya está disponible el boletín del IDIS del mes de noviembre de 2023. Puedes descargártelo en PDF aquí.
La directora científica del IDIS gana el Premio Nóvoa Santos
Asomega reconoce la trayectoria investigadora, clínica y docente de la Dra. Mª Luz Couce, directora científica del IDIS.
Un estudio del IDIS se convierte en portada de la revista Nature Cancer
El estudio liderado por el investigador José Tubío revela un genoma desestructurado en el cáncer de los bivalvos que no existe en otros
Calendar
COMMON SUPPORT PLATFORMS
The platforms are research support units featured by a high strategic value, equipped by cutting edge technologies and operated by highly specialised technical staff.
CALLS
All updated information on public and private competitive calls. The most convenient and safest way to send your requests.
CAREERS
Would you like to join our team? We are always looking for people with a passion for research and propelled by insatiable curiosity to join our mission of providing a better healthcare day every day. Here you can see and apply for our current vacancies.
Research Areas
ONCOLOGY
Improvement of treatments: personalised therapy and reduction of side effects.
GENETICS AND SYSTEMS BIOLOGY
Identification of genetic biomarkers of disease susceptibility and prognosis
ENDOCRINOLOGÍA, NUTRICIÓN Y METABOLISMO
The area studies obesity from different perspectives with the participation of groups from the clinical and basic fields in a synergistic way.
NEUROSCIENCES
Search for new therapeutic targets and improvement of the clinical-therapeutic management of neurological patients, mainly stroke, Alzheimer’s, Parkinson’s disease, headaches and neurological diseases caused by prions.
CARDIOVASCULAR
The general objective of the Cardiovascular Area consists of the search for new therapeutic targets and the improvement of clinical-therapeutic management.
PLATFORMS AND METODOLOGY
The area aims at providing evidence for prioritising the management of public resources, evaluating risks and identifying opportunities for improving the health of the population. From here, prioritise structural investments and action programs.